Compound Management Market is Anticipated to Witness High Growth Owing to Increased Demand from Pharmaceutical and Biotechnology Companies

Compound Management Market is Anticipated to Witness High Growth Owing to Increased Demand from Pharmaceutical and Biotechnology Companies

 It is crucial for storage and supply of compounds for high-throughput screening, drug discovery and chemical biology programs. The growing pharmaceutical and biotechnology industries coupled with rising R&D expenditure is shifting focus on automation and outsourcing of compound management activities to streamline the process of drug discovery.

The global compound management market is estimated to be valued at US$ 436.2 Mn in 2024 and is expected to exhibit a CAGR of 14.7% over the forecast period of 2024 to 2031.

Compound management largely finds applications in drug discovery, chemical synthesis and screening. It helps improve the efficiency of retrieving chemical compounds for experiments, reduces cost of compound acquisition and storage. The need for maintaining a centralized database of compounds across multiple locations is driving demand in the market.

Key Takeaways
Key players operating in the Compound Management are TCG Lifesciences, Wuxi Apptec, Icagen, Evotec, Biosero, Labcyte, TTP Group, Hamilton Company, Tecan, Brooks Automation, Frontier Scientific, Brooks Life Sciences, Titian Software Limited, Beckman Coulter, Inc., BioAscent, LiCONiC AG, SPT Labtech, and Tecan Trading AG. These market leaders are focusing on expanding their compound management platforms and services through acquisitions and partnerships.

There is significant opportunity for companies to tap the growing demand from CROs and pharmaceutical companies outsourcing compound management activities. Market players are investing in developing integrated workflow solutions with LIMS and laboratory automation to streamline drug discovery process and gain high customer satisfaction.

North America dominated the global Compound Management Market Size in 2023 due to presence of large pharmaceutical companies and biotech startups. However, Asia Pacific region is anticipated to witness highest growth owing to increasing investments by international players and growing generics market in India and China. Industry players are expanding their presence through joint ventures and direct sales force in emerging markets.

Market Drivers:
- Increasing R&D expenditure on drug discovery by pharma and biotech companies globally. Spending on R&D is driving demand for efficient compound management solutions.
- Growing trend of outsourcing non-core activities like compound management to CROs. This is propelling market players to invest in expanding service offerings.

Market Restraints:
- High cost of setting up compound management facility. High initial capital requirement can restrict small labs and startups to procure systems.
- Lack of skilled professionals for compound management. Scarcity of trained personnel can hamper growth in developing countries.
Segment Analysis
The Compound Management market is dominated by the services sub-segment which accounts for around 55% share of the market. The compound management services involve sample receipt and transportation, data integration, compound/sample storage and inventory management. Outsourcing of these non-core tasks to compound management service providers helps research organizations focus on their core areas of drug discovery and development. This is the major factor driving the growth of services sub-segment.

The sample storage sub-segment holds the second largest share in the market owing to huge storage capacity requirements for large libraries of chemical and biological samples. Proper sample storage helps maintain sample integrity and identity during the entire drug development lifecycle and is crucial for reproducibility of research outcomes. This sub-segment is expected to witness significant growth over the forecast period.

Global Analysis
North America dominates the global Compound Management Market Size And Trends with the highest share owing to presence of large biopharma companies and CROs (contract research organizations) in the US and Canada. Increased R&D expenditure, technological advancements, and government funding for drug discovery research further support market growth in the region.

Asia Pacific exhibits the fastest growth rate during the forecast period mainly due to expansion of pharmaceutical industry in countries like China and India. Growing biotech sector, outsourcing of early stage drug discovery to Asia Pacific, and increasing investments by global players to tap the healthcare market potential in the region are some key factors fueling market growth.

Get more insights on – Compound Management Market

About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)